[Combined effect of semi-synthetic penicillins (ampicillin and oxacillin) on clinical strains of gram-positive and gram-negative microorganisms].
D000667:Ampicillin / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D010068:Oxacillin / Q000494:pharmacology* / Q000627:therapeutic use; D010403:Penicillin Resistance; D010405:Penicillinase / Q000096:biosynthesis; D011511:Proteus / Q000187:drug effects / Q000201:enzymology; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology; D013210:Staphylococcus / Q000187:drug effects / Q000201:enzymology; D014552:Urinary Tract Infections / Q000188:drug therapy
D000667:Ampicillin; D010405:Penicillinase; D010068:Oxacillin
Kombinirovannoe deĭstvie polusinteticheskikh penitsillinov (ampitsillina i oksatsillina) na klinicheskie shtammy grampolozhitel'nykh i gramotritsatel'nykh mikroorganizmov.